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Abstract: The primary amino acid sequence of the hepatitis B virus (HBV) proteome was 
searched for identity spots in the human proteome by using the Protein Information Resource 
database. We find that the HBV polyprotein shares sixty-five heptapeptides, one octapeptide, 
and one nonapeptide with the human proteins. The viral matches are disseminated among 
fundamental human proteins such as adhesion molecules, leukocyte differentiation antigens, 
enzymes, proteins associated with spermatogenesis, and transcription factors. As a datum of 
special interest, a number of peptide motifs are shared between the virus- and brain-specific 
antigens involved in neuronal protection. This study may help to evaluate the potential cross 
reactions and side effects of HBV antigen-based vaccines.
Keywords: HBV proteome, human proteome, similarity analysis, viral versus human proteome 
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Introduction
Vaccination for infectious diseases may be associated with potential adverse events and 
possible long-term health disorders (see http://www.cdc.gov/vaccinesafety). Indeed, 
antigen-specific immunotherapy protocols may target not only the antigen from the 
infectious microorganism, but also host tissues expressing antigens that share sequences 
with the target.1 In general, a vaccine produces a weak immune response; also auto-
immune cross-reactions are extremely rare events.2–5 Under normal non-stimulated 
conditions, immune system fails to make immune responses to protein vaccines, unless 
adjuvants are added.6,7 Consequently, the active vaccine preparations currently in use 
contain adjuvants for obvious reasons of desired immunogenicity,8,9 so intrinsically 
carrying a certain degree of inducing/enhancing a potential cross-reactivity risk.
In order to define quantitatively and qualitatively the molecular basis of active 
vaccine (auto)immunity, we are undertaking proteomic sequence-to-sequence profile 
analyses between microbial versus human proteins.10 Here, the HBV polyprotein was 
examined for amino acid sequence similarity to the human proteome at the heptamer 
level. We describe a high level of sharing of heptapeptide motifs between HBV and 
human proteins, with numerous neuronal proteins involved in the viral versus human 
peptide overlapping.
Methods
The HBV polyprotein primary sequence (Taxonomic ID: 10407; EMBL 
  Accession: X51970) was dissected into heptamers that were analyzed for exact 
sequence similarity to the human proteome using PIR perfect match program Biologics: Targets & Therapy 2010:4 76
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(http://pir.georgetown.edu/pirwww/search/peptide.shtml). 
The heptamers were offset by one residue, ie, overlapping 
by six residues: ie, MQLFHLC, QLFHLCL, LFHLCLI, 
FHLCLII, etc. The human proteome consisted of 36,103 
proteins at the time of analysis. The function of the human 
proteins and potential disease associations were analyzed 
using the Universal Protein Resource (UniProt; see http://
www.uniprot.org/uniprot). Repeated sequences, fragments, 
and uncharacterized entries were filtered out.
Results
HBV proteins were analysed for amino acid sequence identity 
to the human proteome using heptamers as scanning units. The 
theoretical probability of a sequence of 7 amino acids occur-
ring at random in two proteins may be calculated as 20−7 or 1 in 
1 280,000,000,1 assuming that all amino acids occur with the 
same frequency. Moreover, to determine the number of times a 
given viral heptamer might occur at random in the human 
proteome, one must consider the size of the viral and human 
proteomes. The analyzed human proteome was formed by 
36,103 proteins and 10,431,975 unique 7-mers, and the HBV 
polyprotein was formed by 1,586 unique 7-mers10 Therefore, 
the number of times we would see a HBV 7-mer at random in 
the human proteome is 20−7 times the number of 7-mers in the 
two proteomes. This probability is 12.9. In contrast, Table 1 
illustrates that HBV proteins actually share peptide sequences 
with the human proteome for a total of 65 heptamers. The table 
also shows that HBV and human proteomes also share one 
octamer (RLGLSRPL peptide, AA Pos 796-803 in the HBV 
polymerase protein) and one nonamer (SPRRRTPSP peptide, 
AA Pos 186–194 in the viral HBV core protein).
Moreover, Table 1 shows that the human proteins hosting 
heptapeptides from HBV proteome comprehend numerous 
critical antigens specifically (or, in a few instances, uniquely) 
expressed in the brain. The critical neuronal role exerted by 
the human molecules hosting viral motifs is illustrated by the 
following examples. RNF19 or E3 ubiquitin-protein ligase is 
involved in neuronal protection,47 BSN or protein bassoon is 
exclusively expressed in brain and functions in the organiza-
tion of the cytomatrix at the nerve terminals active zone which 
regulates neurotransmitter release,51 CENG1 or phosphati-
dylinositol-3-kinase enhancer participates in the prevention 
of neuronal apoptosis,23 and so on. Obviously, it is logical to 
postulate that immune cross-reactions with these neuronal anti-
gens might carry a sequela of inflammatory brain lesions.
Furthermore, Table 1 shows that another set of human 
proteins hosting 7-mer viral motifs is represented by 
spliceosomal proteins.18,21,25 This datum is worth noting 
in the light of the numerous reports on a possible link 
between splicing phenomena and neurodegenerative dis-
eases. Indeed, (dysregulated) splicing has been implicated 
in the: 1) selection of the autoimmune T-cell repertoire in 
multiple sclerosis;66 2) reduction of the adenosine A1 recep-
tor-β transcript in MS patients, that potentially leads to 
increased macrophage activation and central nervous system 
inflammation;67 3) expression of the citrullinated myelin 
basic protein isomer, an autoantigen in multiple sclerosis;68 
4) generation of alternatively spliced transcripts of the gene 
for human Cu, Zn superoxide dismutase, a causative gene 
for autosomal dominant amyotrophic lateral sclerosis.69 
Moreover, a complex splicing pattern characterizes the 
human myelin/oligodendrocyte glycoprotein, an highly 
encephalitogenic autoantigen and a target for autoaggres-
sive immune responses in CNS inflammatory demyelinating 
diseases.70 Finally, aberrant splicing has been involved in 
the generation of an aberrant transcript of excitatory amino 
acid transporter 2 that has been associated with amyotrophic 
lateral sclerosis.71 In this regard, it is also remarkable that 
the long viral nonamer motif, ie, the SPRRRTPSP peptide 
sequence (aa pos 186–194 in the viral HBV Core protein), 
is present in the human Ser/Arg repetitive matrix protein 1 
(SRRM1), that is part of pre- and post-splicing multiprotein 
mRNP complexes.21 SSRM1 is involved in a number of pre-
mRNA processing events (see Table 1 for details). Again, it is 
quite logical to postulate that a cross-reaction with SRRM1 
would alter a number of physiological functions.
Discussion
To our knowledge, this study is the first and most important 
of its kind in providing a clear-cut analysis of the identity 
platform linking HBV and Homo sapiens proteomes. Two 
considerations emerge from the data reported here. First, 
although the theoretical probability of sharing perfect 
identical heptapeptide fragments is relatively low, actually 
we find 65 perfect identical matches between the viral and 
human proteomes. Based on the need for five or six amino 
acids to induce a monoclonal antibody response,1,72 the 65 
heptapeptide overlaps might clearly induce autoimmune reac-
tions. Second, the nature of the overlapping is also of interest 
since a number of viral motifs occur in human proteins that are 
crucially involved in the neuronal structure and functions.
Given the premises illustrated under the Introduction, 
these data warn against adverse side-effects of active 
  vaccination using entire HBV antigens. In parallel, the 
present study might be useful for designing anti-HBV vac-
cines based on not-shared portions of the viral antigens. More Biologics: Targets & Therapy 2010:4 77
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Table 1 Sharing of 7-mer motifs between HBV and human proteomes. Location in the viral protein and amino acid sequence of the 
heptapeptide motifs are reported. The human proteins sharing heptapeptides with the HBV proteome are characterized by accession 
number and available data on function, location, and disease association (www.uniprot.org/)
HBV Human proteins hosting heptapeptides from HBV proteome Ref
Core protein:  
Aa Pos Sequence
44 LLSFLPS Q6ZNP3: CDNA FLJ27406 fis. 11
53 FPSVRDL Q96IQ9: Zinc finger protein 414. 12
60 LDTASAL SEM3F: Semaphorin 3F variant. 13
66 LYREALE NARG1: NMDA receptor-regulated protein 1. Involved in vascular and neuronal growth and development. Controls  
retinal neovascularization. Found in brain (corpus callosum).
14
70 ALESPEH LYAM2: E-selectin or endothelial leukocyte adhesion molecule. Involved in the adhesion of blood neutrophils in  
cytokine-activated endothelium, and in capillary morphogenesis.
15
132 FRISYLT Q6ZN37: Flap endonuclease GEN homolog 1. Cleaves flap structures at the junction between single-stranded DNA 
and double-stranded DNA. Specific for 5’-overhanging flap structures in which the 5’-upstream of the flap is  
completely double-stranded.
16
172 LPETTVV UCK1: Uridine-cytidine kinase 1. Phosphorylates uridine and cytidine to UMP and CMP. 17
179 RRRDRGR PRP4B: Serine/threonine-protein kinase PRP4 homolog. Has a role in pre-mRNA splicing. Identified in the spliceosome 
C complex, at least composed of AQR, ASCC3L1, C19orf29, CDC40, CDC5L, CRNKL1, DDX23, DDX41, DDX48,  
DDX5, DGCR14, DHX35, DHX38, DHX8, EFTUD2, FRG1, GPATC1, HNRPA1, HNRPC, HNRPF, HNRPM, HNRPR,  
LSM2, MAGOH, MORG1, PABPC1, RBM22, RBM8A, RBMX, SART1, SF3A1, SF3A2, SF3A3, SF3B1, SF3B2, SF3B3, SFRS1, 
SKIV2L2, SNRPA1, SNRPB, SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF, SNRPG, SNW1, SRRM1, SRRM2, SYF2,  
SYNCRIP,   TFIP11, THOC4, U2AF1, WDR57, XAB2, ZCCHC8, et cetera.
18
180 RRDRGRS Q4VX62: Putative uncharacterized protein C6orf99. 19
183 RGRSPRR Q5TZA2: Rootlet coiled-coil protein. Contributes to centrosome cohesion before mitosis. 20
186 SPRRRTP SRRM1: Ser/Arg repetitive matrix protein 1. Part of pre- and post-splicing multiprotein mRNP complexes. Involved in  
pre-mRNA processing events. Identified in the spliceosome C complex, at least composed of AQR, ASCC3L1, CDC40, 
CDC5L, CRNKL1, DDX23, DDX41, DDX48, DDX5, DGCR14, DHX35, DHX8, EFTUD2, FRG1, GPATC1, HNRPA1,  
HNRPC, HNRPF, HNRPH1, HNRPK, HNRPM, HNRPR, HNRPU, LSM2, MAGOH, MORG1, PABPC1, PLRG1, PNN, PPIE, 
PPIL1, PPWD1, PRPF19, PRPF4B, PRPF6, PRPF8, RALY, RBM22, RBMX, SART1, SF3A1, SKIV2L2, SNRPA1, SNRPB,  
SNRPD1, SNRPD2, SNRPD3, SNRPE, SNRPF, SNRPG, SNW1, SRRM1, SRRM2, SYF2, SYNCRIP,   TFIP11, THOC4,  
U2AF1, WDR57, XAB2, ZCCHC8, et cetera.
21
187 PRRRTPS SRRM1 – see above. 21
188 RRRTPSP SRRM1 – see above. 21
Q8WZ42: Titin. Connectin. Rhabdomyosarcoma antigen MU-RMS-40.14 Key component in the functioning of  
vertebrate striated muscles. Contributes to the fine balance of forces between the two halves of the sarcomere.  
In non-muscle cells, seems to play a role in chromosome condensation and chromosome segregation during mitosis.
22
191 TPSPRRR CENG1: Centaurin-γ-1 or Phosphatidylinositol-3-kinase enhancer. Participates in the prevention of neuronal apoptosis  
by enhancing PI3 kinase activity. Involved in the coupling of metabotropic glutamate receptor 1 to cytoplasmic  
PI3 kinase by interacting with Homer scaffolding proteins. Mediates anti-apoptotic effects of NGF by activating PI3 kinase.
23
192 PSPRRRR Q6ZNH0: Tau-tubulin kinase 1. Ser/thr kinase which phosphorylates TAU. Induces aggregation of TAU. Expressed in  
cortical and hippocampal neurons.
24
Q8N8X8 cDNA FLJ38717 fis, clone KIDNE2009647. 16
193 SPRRRRS SFR11 Splicing factor, arginine/serine-rich 11. 25
196 RRRSQSP BOP1: Ribosome biogenesis protein BOP1. Required for maturation of the 25S and 5.8S ribosomal RNAs. 26
201 SPRRRRS SFR11: Splicing factor, Arg/Ser-rich 11 that localizes with spliceosome components. 25
Polymerase protein:   
Aa Pos Sequence
20 AGPLEEE BIEA: Biliverdin reductase A Reduces the γ-methene bridge of the open tetrapyrrole, biliverdin IX α, to bilirubin  
with oxidation of a NAD(P)H cofactor.
27
24 EEELPRL CHD5 Chromodomain-helicase-DNA-binding protein 5. May play a role in the development of the nervous system  
and the pathogenesis of neural tumors. Preferentially expressed in total brain, fetal brain, and cerebellum.
28
198 SFCSQPS BARD1: BRCA1-associated RING domain protein 1 Implicated in BRCA1-mediated tumor suppression. Functions in  
the response to DNA damage.
29
204 SGILSRS RCOR2: REST corepressor 2. 30
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Table 1 (Continued)
HBV Human proteins hosting heptapeptides from HBV proteome Ref
Polymerase protein:   
Aa Pos Sequence
264 SGHVDPS TAF1C: TATA box-binding protein-associated factor RNApol I subunit C. 31
308 CLPPSSA TICAM-1 or Toll-Interleukin 1 receptor domain-containing adapter protein inducing INF-β. Involved in innate  
immunity against invading pathogens. Adapter used by TLR3 and TLR4 to mediate NFkB and IRF activation,  
and to induce apoptosis. Ubiquitously expressed.
32
315 RPQSQGS Q8N7I0:   Tigger transposable element derived 1-like 2. 33
363 RIPRTPA ZDHC1: Probable palmitoyltransferase ZDHHC1. 34
372 TGGVFLV Q2TBD6: Urea transporter, kidney specialized low-affinity vasopressin-regulated urea transporter. Has a role in  
the urinary concentrating mechanism.
35
385 TAESRLV Q15751: E3 ubiquitin-protein ligase. Binds phosphatidylinositol-4,5-bisphosphate, which is required for GEF activity.  
Acts as a E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme and then  
transfers the ubiquitin to targeted substrates.
36
417 LTNLLSS Q68DA7: Formin-1, Limb deformity protein homolog. Plays a role in the formation of adherens junction and the  
polymerization of linear actin cables.
37
537 SVVRRAF FFAR2: Free fatty acid receptor 2. The rank order of potency for agonists of this receptor is  
acetate = propionate = butyrate  pentanoate = formate.
38
575 FLLSLGI XCR1: Chemokine XC receptor 1. Receptor for chemokines SCYC1 and SCYC2. Subsequently transduces 
 a signal by increasing the intracellular calcium ions level.
39
583 LNPNKTK CD68: MacrosialinCD_antigen. CD68. Plays a role in phagocytic activities of tissue macrophages. Binds  
to tissue- and organ-specific lectins or selectins, allowing homing of macrophage subsets to particular  
sites. Highly expressed by monocytes and macrophages.
40
643 GFAAPFT CQ10A Protein COQ10 A, mitochondrial. 41
667 QAFTFSP Q6QLU7 Mitogen-activated protein kinase 7. Plays a role in various cellular processes such as proliferation,  
differentiation and cell survival.
42
796 RLGLSRPl Q5JSZ5 Protein BAT2-like or HLA-B-associated transcript 2-like. 16
797 LGLSRPL Q5JSZ5 as above. 16
798 GLSRPLL Q9UFD9 RIMS-binding protein 3A. 43
799 LSRPLLR Q53EQ6 Tigger transposable element-derived protein 5. 16
811 TTGRTSL ECT2 Epithelial cell-transforming sequence 2 oncogene. 16
Large Envelope protein:   
Aa Pos Sequence
89 STIPPPA VMAT1: Chromaffin granule amine transporter.   Vesicular transport of biogenic amines. 44
142 PAGGSSS NRG2: Pro-neuregulin-2. Neural- and thymus-derived activator for ERBB kinases. 45
143 AGGSSSG CCNL1: Cyclin-L1. Transcriptional regulator of the pre-mRNA splicing process. May be a candidate  
protooncogene in head and neck squamous cell carcinomas. Ubiquitous.
46
RNF19: E3 ubiquitin-protein ligase. Transfers ubiquitin to targeted substrates. Specifically ubiquitinates pathogenic  
SOD1 variants (not wild-type SOD1) which cause amyotrophic lateral sclerosis, so leading to their proteasomal  
degradation and to neuronal protection. Present in the hyaline bodies found in motor neurons from amyotrophic  
lateral sclerosis patients. Present in the Lewy bodies found in neurons from Parkinson disease patients.
47
144 GGSSSGT CCNL1: see above. 46
145 GSSSGTV Q8N5F4 IGL@ protein. 48
185 PLPVLQA PO210: Nuclear pore membrane glycoprotein 210. Essential for nuclear pore assembly fusion, and spacing.  
Recognized by antinuclear autoantibodies in primary biliary cirrhosis.
49
186 LPVLQAG Q6NSZ9: Zinc finger protein 498. 50
217 GGSPVCL BSN: Protein bassoon. Involved in the organization of the cytomatrix at the nerve terminals active zone. Regulates  
neurotransmitter release from a subset of brain glutamatergic synapses. Localized to the active zone of presynaptic  
density Exclusively expressed in brain.
51
227 SRSPTSN Q86X29: Lipolysis-stimulated lipoprotein receptor. 52
254 FIIFLFI GIMA5: GTPase IMAP family member 5 Immunity-associated nucleotide 4-like 1 protein. Required for mitochondrial  
integrity and T-cell survival. Widely expressed.
53
256 IFLFILL KI3L2: Killer cell immunoglobulin-like receptor 3DL2. Inhibits the activity of NK cells thus preventing cell lysis. 54
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Table 1 (Continued)
HBV Human proteins hosting heptapeptides from HBV proteome Ref
Large Envelope protein:  
  Aa Pos Sequence
257 FLFILLL KI3L2 as above. 54
262 LLCLIFL Q6ZVP3 cDNA FLJ42265 fis, clone TKIDN2014771. 55
263 LCLIFLL Q6GU65 HHIP-like protein 2. 56
286 GSTTTST LPHN3: Latrophilin-3. Calcium-independent α-latrotoxin receptor 3. 57
287 STTTSTG UBQL2: Ubiquilin-2. Increases the half-life of proteins destined to be degraded by the proteasome. Interacts  
with the 19S proteasome subunit.
58
343 RFSWLSL Q6ZUX8: cDNA FLJ43235 fis, clone HCHON2004007. 59
X protein:   
Aa Pos Sequence
36 TLSSPSP ZN583: Zinc finger protein 583 May be involved in transcriptional regulation. 16
37 LSSPSPS OXER1: Oxoeicosanoid receptor 1. Receptor for eicosanoids and polyunsaturated fatty acids such as  
5-OXO-ETE, 5(S)-HPETE, arachidonic acid.
60
38 SSPSPS A CUL4B: Cullin-4B. Core component of E3 ubiquitin-protein ligase complexes which mediate the ubiquitination  
and subsequent proteasomal degradation of target proteins. Required for histone H3 and H4 ubiquitination in  
response to UV. Defects in CUL4B cause mental retardation-hypotonic facies syndrome type 2, microcephaly,  
short stature, macrostomia, patulous lips, difficulty in speech, micrognathia, short thumbs and little fingers,  
hypotonia at age less than 10 years, hypertonia, restlessness, and seizures. IQ: from 40 to 57.
61
Q8NEN5: Sperm-specific antigen 2. Involved in early cleavage of the fertilized oocyte. 62
96 RTLGLPA I15RA: Interleukin-15 receptor α. Expressed in fetal brain (mainly in the hippocampus). 63
104 STTDLEA Q5JTZ9: mitochondria alanyl-tRNA synthetase. 64
121 EELGEEI MYH8: Myosin heavy chain 8. Defects cause Carney syndrome characterized by spotty skin pigmentation,  
myxomas, endocrine tumors, and psammomatous melanotic schwannomas.
65
in general, the data reported in this study define a practicable 
procedure to define possible cross-reactions potentially asso-
ciated with active vaccines.
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